CSF2 and type 1 diabetes mellitus: GM-CSF acts mainly on DCs and leads to the expansion of Foxp3+ Tregs, thus delaying the onset of T1D in NOD mice, and this inhibition may be mediated by enhanced IL-10 and TGF-β1 production (50).